New South Wales, Australia

Melissa Thomas

This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Clinical Genomics Pty. Ltd.. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa Thomas - Innovator in Colorectal Cancer Screening

Introduction

Melissa Thomas is a prominent inventor based in New South Wales, Australia. She has made significant contributions to the field of medical diagnostics, particularly in the area of colorectal cancer screening. Her innovative approach aims to improve the accuracy of cancer classification, which is crucial for effective treatment and patient outcomes.

Latest Patents

Melissa Thomas holds a patent for a method of screening for colorectal cancer. This invention relates to determining the probabilities of classifying a neoplasm into various neoplastic categories. Specifically, it focuses on assessing the probability of classifying a large intestine neoplasm into categories such as adenoma, stage I, stage II, stage III, or stage IV. The method involves screening for changes in the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP, and CAHM. This innovative method is beneficial for diagnosing and monitoring colorectal neoplasms, including colorectal adenocarcinosis.

Career Highlights

Melissa is associated with Clinical Genomics Pty. Ltd., where she continues to advance her research and development efforts. Her work is instrumental in enhancing the methodologies used in cancer diagnostics, thereby contributing to the broader medical community.

Collaborations

Melissa has collaborated with notable colleagues, including Lawrence Charles Lapointe and Susanne Kartin Pedersen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical research.

Conclusion

Melissa Thomas is a trailblazer in the realm of colorectal cancer screening, with her patented method poised to make a significant impact on patient care. Her dedication to improving diagnostic techniques exemplifies the vital role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…